{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:23:50Z","timestamp":1783023830789,"version":"3.54.6"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The purpose of the study is to evaluate the effects of anticardiolipin (aCL) and\/or anti-\u03b22-glycoprotein-I (a\u03b22GPI) antibodies, namely antiphospholipid antibodies (aPL), on <jats:italic>in vitro<\/jats:italic> fertilization (IVF)\u00a0outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>The study group comprised infertile women with aPL undergoing IVF-ET cycles. Controls were infertile women with tubal etiology without aPL. The impact of aPL on reproductive outcomes, such as oocyte quality, embryo quality, and implantation capacity, was compared between the study group and controls. Additionally, peripheral blood T cell subsets, such as T helper (Th)1, Th2, Th17, and T regulatory (Treg) cells and cytokines, were analyzed by the flow cytometry. Differences between the study group and controls were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 132 infertile women, including 44 women with aPL, and 88 controls were sequentially recruited for this study. Women with aPL had lower numbers of total and perfect\/available embryos and lower rates of MII oocytes, blastocyst formation, perfect and available embryos, implantation, clinical pregnancy, and take-home baby. Additionally, imbalanced Th1\/Th2 and Th17\/Treg ratios, significantly higher levels of serum IL-2, TNF-\u03b1, IFN-\u03b3, and IL-17A, and a significantly lower serum IL-4 were noticed in women with aPL compared to controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Women with aPL such as aCL and\/or a\u03b22GPI antibodies were associated with adverse IVF outcomes. Early screening for aPL and appropriate consultation for couples undergoing IVF should be considered. In addition, underlying immunopathology and inflammatory immune mechanisms associated with aPL should be further explored.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.986893","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T09:44:43Z","timestamp":1667382283000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Anticardiolipin and\/or anti-\u03b22-glycoprotein-I antibodies are associated with adverse IVF outcomes"],"prefix":"10.3389","volume":"13","author":[{"given":"Li","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanshi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Kwak-Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"101463","DOI":"10.1016\/j.berh.2019.101463","article-title":"Antiphospholipid syndrome","volume":"34","author":"Sammaritano","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00205","article-title":"Antiphospholipid antibodies and antiphospholipid syndrome during pregnancy: Diagnostic concepts","volume":"6","author":"Levy","year":"2015","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(17)30066-X","article-title":"Antiphospholipid syndrome","author":"Cervera","year":"2017","journal-title":"Thromb Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314529171","article-title":"Antiphospholipid antibodies and infertility","volume":"23","author":"Chighizola","year":"2014","journal-title":"Lupus"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/art.40901","article-title":"The epidemiology of antiphospholipid syndrome: A population-based study","volume":"71","author":"Duarte-Garcia","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a019352","article-title":"Antiphospholipid antibodies in women having in-vitro fertilization","volume":"11","author":"Birdsall","year":"1996","journal-title":"Hum Reprod"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314525865","article-title":"Prevalence of antiphospholipid antibodies in patients with sterility undergoing 'in vitro' fertilization","volume":"23","author":"Proietta","year":"2014","journal-title":"Lupus"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2011.01058.x","article-title":"Impact of anticardiolipin antibody on the outcome of in vitro fertilization and embryo transfer","volume":"66","author":"Zhong","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2017.07.006","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"31","author":"Chaturvedi","year":"2017","journal-title":"Blood Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"103459","DOI":"10.1016\/j.jri.2021.103459","article-title":"Anti-Ro\/SSA and\/or anti-La\/SSB antibodies are associated with adverse IVF and pregnancy outcomes","volume":"149","author":"Fang","year":"2022","journal-title":"J Reprod Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1477-7827-11-98","article-title":"A retrospective study on IVF\/ICSI outcome in patients with anti-nuclear antibodies: the effects of prednisone plus low-dose aspirin adjuvant treatment","volume":"11","author":"Zhu","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"17103","DOI":"10.1038\/nrdp.2017.103","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50262","article-title":"Antiphospholipid syndrome: a clinical review","volume":"211","author":"Mezhov","year":"2019","journal-title":"Med J Aust"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9857-y","article-title":"Decreased levels of circulating CD4+CD25+Foxp3+ regulatory T cells in patients with primary antiphospholipid syndrome","volume":"33","author":"Dal Ben","year":"2013","journal-title":"J Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2012.1055","article-title":"Th1\/Th2\/Th17\/Treg expression in cultured PBMCs with antiphospholipid antibodies","volume":"6","author":"Xiao","year":"2012","journal-title":"Mol Med Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2017.11.026","article-title":"Autoimmune thyroid diseases and Th17\/Treg lymphocytes","volume":"192","author":"Shao","year":"2018","journal-title":"Life Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01027","article-title":"T Cell metabolism: A new perspective on Th17\/Treg cell imbalance in systemic lupus erythematosus","volume":"11","author":"Shan","year":"2020","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030338","article-title":"Heterogeneity, and plasticity","volume":"10","author":"Zhu","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203622","article-title":"A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients","volume":"73","author":"Erkan","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2016.12.020","article-title":"Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization","volume":"91","author":"Niu","year":"2017","journal-title":"Cytokine"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.448","article-title":"Treg deficiency-mediated TH 1 response causes human premature ovarian insufficiency through apoptosis and steroidogenesis dysfunction of granulosa cells","volume":"11","author":"Jiao","year":"2021","journal-title":"Clin Transl Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.07.015","article-title":"Humoral and cellular autoimmunity in women with recurrent pregnancy losses and repeated implantation failures: A possible role of vitamin d","volume":"15","author":"Kwak-Kim","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0897.2003.01197.x","article-title":"Antiphospholipid antibodies in implantation failures","volume":"49","author":"McIntyre","year":"2003","journal-title":"Am J Reprod Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/aji.12114","article-title":"Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome","volume":"69","author":"Kwak-Kim","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/molehr\/4.1.77","article-title":"Profile of cytokine mRNA expression in peri-implantation human endometrium","volume":"4","author":"Lim","year":"1998","journal-title":"Mol Hum Reprod"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2005.03.008","article-title":"Th1\/Th2 cytokines balance\u2013yin and yang of reproductive immunology","volume":"122","author":"Wilczynski","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12474","article-title":"The multifaceted actions of leukaemia inhibitory factor in mediating uterine receptivity and embryo implantation","volume":"75","author":"Rosario","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der301","article-title":"An imbalance in interleukin-17-producing T and Foxp3(+) regulatory T cells in women with idiopathic recurrent pregnancy loss","volume":"26","author":"Lee","year":"2011","journal-title":"Hum Reprod"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2018.11.002","article-title":"T Cell subsets in peripheral blood of women with recurrent implantation failure","volume":"131","author":"Ghaebi","year":"2019","journal-title":"J Reprod Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(11)91563-4","article-title":"Regulatory effect of antiphospholipid antibodies on signal transduction: a possible model for autoantibody-induced reproductive failure","volume":"167","author":"Gleicher","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2004.07.978","article-title":"Antiphospholipid antibodies prevent extravillous trophoblast differentiation","volume":"83","author":"Quenby","year":"2005","journal-title":"Fertil Steril"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317692432","article-title":"Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: the influence of a triple positive antibody profile","volume":"26","author":"Latino","year":"2017","journal-title":"Lupus"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2017.08.001","article-title":"Factors associated with adverse pregnancy outcomes in women with antiphospholipid syndrome: A multicenter study","volume":"122","author":"Deguchi","year":"2017","journal-title":"J Reprod Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31820a61f9","article-title":"ACOG practice bulletin no. 118: antiphospholipid syndrome","volume":"117","year":"2011","journal-title":"Obstet Gynecol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/art.41191","article-title":"2020 American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/biomedicines8110508","article-title":"Management of antiphospholipid syndrome","volume":"8","author":"Ghembaza","year":"2020","journal-title":"Biomedicines"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez419","article-title":"Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry","volume":"59","author":"Alijotas-Reig","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01287.x","article-title":"The use of LMWH in pregnancies at risk: new evidence or perception","volume":"3","author":"Walker","year":"2005","journal-title":"J Thromb Haemost"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-008-0170-y","article-title":"Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? yes (in some cases)","volume":"3","author":"Gerosa","year":"2008","journal-title":"Intern Emerg Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"108259","DOI":"10.1016\/j.clim.2019.108259","article-title":"Heparin and aspirin combination therapy restores T-cell phenotype in pregnant patients with antiphospholipid syndrome-related recurrent pregnancy loss","volume":"208","author":"Wang","year":"2019","journal-title":"Clin Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029146","article-title":"Serum antiphospholipid antibody status may not be associated with the pregnancy outcomes of patients undergoing in vitro fertilization","volume":"101","author":"Tan","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1422.048","article-title":"Antigenic profile, prevalence, and clinical significance of antiphospholipid antibodies in women referred for in vitro fertilization","volume":"1108","author":"Sanmarco","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.2018.61.3.359","article-title":"Impact of presence of antiphospholipid antibodies on in vitro fertilization outcome","volume":"61","author":"Hong","year":"2018","journal-title":"Obstet Gynecol Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jri.2017.08.002","article-title":"Association of serum autoantibodies with pregnancy outcome of patients undergoing first IVF\/ICSI treatment: A prospective cohort study","volume":"122","author":"Chen","year":"2017","journal-title":"J Reprod Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.986893\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T09:44:47Z","timestamp":1667382287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.986893\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":46,"alternative-id":["10.3389\/fimmu.2022.986893"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.986893","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]},"article-number":"986893"}}